Company Profile
Vaccinex Stock Price, News & Catalysts
- Ticker:
- VCNX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.78 USD (-6.83%)
Close
Last updated: August 17, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for VCNX.
Company overview
Business overview
Vaccinex is a biotechnology company focused on antibody therapies and immunology, with a history of pursuing difficult oncology and neurodegenerative targets. Its story is tied to platform science and the challenge of turning it into durable value.
Geographic Base and Sector Classification
Vaccinex is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with a therapeutic platform focus.
Business Model Characteristics
The business model depends on clinical validation, strategic partnerships, and capital management. Investors typically track early data, platform breadth, and whether the company can progress a narrow pipeline without dilution pressure.
Position Within the Biotechnology Landscape
Vaccinex sits in a high-risk platform-biotech niche. It remains catalyst-sensitive because the company's value depends on a limited number of programs and the market's belief in its science.
Future catalysts
- Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame. That breadth is useful, but the company now needs one of those programs to move from scientific promise to something more concrete.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vaccinex (VCNX)?
Vaccinex (VCNX) most recently closed at 0.78 USD, a -6.83% move versus the previous session.
What does Vaccinex do?
Vaccinex is a biotechnology company focused on antibody therapies and immunology, with a history of pursuing difficult oncology and neurodegenerative targets. Its story is tied to platform science and the challenge of turning it into durable value.
On which exchange is VCNX stock listed?
Vaccinex (VCNX) is associated with NASDAQ, United States, Biopharma.
What is Vaccinex?
Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame.
Which conditions is Vaccinex targeting with Vaccinex?
Vaccinex is associated with oncology, cancer therapeutics, immunology based on its company overview and current catalyst commentary.
How does Vaccinex describe recent progress with Vaccinex?
Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame.
What is Alzheimer?
Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame.
What should investors watch for with Alzheimer?
Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame.